# Ernexa Therapeutics Inc.: Form SCHEDULE 13D/A, filed Feb 17, 2026

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-17
- Accepted by EDGAR: Feb 17, 2026, 21:26 ET
- Period: not reported
- Accession: 0001104659-26-016685
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000110465926016685/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000110465926016685/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000110465926016685/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-016685. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.